Stay updated on Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial
Sign up to get notified when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2Fq5kIb-H8wc2ihfcGyhO8N_cFeqI.uncropped.jpg&w=3840&q=75)
Latest updates to the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoChange DetectedThe study has been updated to version v2.10.0, indicating a new release with potentially significant changes, while the previous version v2.9.7 has been removed.SummaryDifference0.3%
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7, replacing the previous version v2.9.6.SummaryDifference0.1%
- Check16 days agoChange DetectedDifference0.2%
- Check17 days agoChange DetectedDifference0.2%
- Check23 days agoChange DetectedThe value 'Ovarian Epithelial Cancer Fallopian Tube Cancer' has been changed to 'Fallopian Tube Cancer Ovarian Epithelial Cancer'. This represents a reversal in the order of the cancer types listed in the study title.SummaryDifference0.2%
- Check24 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
Stay in the know with updates to Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.